Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Discusses the reasons behind the high failure rate of drug candidates translating from preclinical research to clinical application.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Levchenko et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: